Amy N. Sussman

Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy

Fernando C. Fervenza, Gerald B. Appel, Sean J. Barbour et al. · New England Journal of Medicine · 2019 · 600 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Serum Isoform [−2]proPSA Derivatives Significantly Improve Prediction of Prostate Cancer at Initial Biopsy in a Total PSA Range of 2–10 ng/ml: A Multicentric European Study

Massimo Lazzeri, Alexander Haese, Alexandre de la Taille et al. · European Urology · 2013 · 212 citations

Medicine, Biochemistry, Oncology +16

A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR)

Fernando C. Fervenza, Pietro A. Canetta, Sean J. Barbour et al. · ˜The œNephron journals/Nephron journals · 2015 · 69 citations

Medicine, Immunology, Nephrology +15

An international cohort study of autosomal dominant tubulointerstitial kidney disease due to mutations identifies distinct clinical subtypes

Martina Živná, Kendrah Kidd, Mohamad Zaidan et al. · Kidney International · 2020 · 43 citations · Full text

Medicine, Internal Medicine, Nephrology +13

Outcome of Patients on Combined Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy: A Retrospective Study

Bijin Thajudeen, Mahmoud Kamel, Cibi Arumugam et al. · The International Journal of Artificial Organs · 2015 · 37 citations

Medicine, Nephrology, Dialysis +11